Subscribe to our Newsletter

Receive our latest trending news and business updates in your inbox.

Opt in to receive news and updates. By ticking the checkbox, you agree with Privacy Policy.

Thank you!

You have successfully joined our subscriber list.

World
Trending News
Stock Market
Business
Investing
Politics
Tech
- Crypto-Assets
Lifestyle
Marketing
About Us
Contacts

FDA approval

Stock Market

Sarepta Therapeutics surges 32% on expanded FDA approval for Duchenne gene therapy

Sarepta Therapeutics (NASDAQ) saw its shares soar 32% at market open on Friday following the FDA’s expanded approval of...

By Guntakin Mehnatli
June 23, 2024

Subscribe to our Newsletter

Receive our latest trending news and business updates in your inbox.

Opt in to receive news and updates. By ticking the checkbox, you agree with Privacy Policy.

Thank you!

You have successfully joined our subscriber list.

About Us
Contacts
Terms and Conditions
Privacy Policy
Disclaimer

Copyright © 2024 Finblog.com. The content on this site is not intended to be investment advice. Investing involves risk, and your capital is at risk when investing. This site is not for use in jurisdictions where the described trading or investments are prohibited and should only be used in legally permitted ways. Your investment may not be eligible for investor protection in your country or state of residence, so please perform your own due diligence. While this website is free to use, we may receive commissions from the companies featured on this site.

World
Trending News
Stock Market
Business
Investing
Politics
Tech
- Crypto-Assets
Lifestyle
Marketing
About Us
Contacts

Start typing and press Enter to search